A detailed history of Org Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Org Partners LLC holds 1,294 shares of BMY stock, worth $52,342. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,294
Previous 3,982 67.5%
Holding current value
$52,342
Previous $204,000 65.69%
% of portfolio
0.15%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $128,970 - $146,227
-2,688 Reduced 67.5%
1,294 $70,000
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $214,281 - $255,697
-4,420 Reduced 52.61%
3,982 $204,000
Q3 2023

Nov 03, 2023

BUY
$57.89 - $64.73 $259,520 - $290,184
4,483 Added 114.39%
8,402 $326 Million
Q2 2023

Jul 25, 2023

BUY
$63.71 - $70.74 $249,679 - $277,230
3,919 New
3,919 $252 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.